The clonally unrelated RT, RT-1 which harbors a GC phenotype, showed the presence of MYD88, a CLL driver mutation, as well as mutations in genes implicated in cancer pathogenesis, TET2 and KMT2D, which have also been seen in RT [18]. This evidence concerns the gene MYD88 and cancer.